Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 17 years, with Q2 2025 value amounting to $239.3 million.

  • Lifecore Biomedical, Inc. \De\'s Liabilities and Shareholders Equity fell 575.6% to $239.3 million in Q2 2025 from the same period last year, while for May 2025 it was $979.2 million, marking a year-over-year decrease of 124.97%. This contributed to the annual value of $239.3 million for FY2025, which is 575.6% down from last year.
  • Per Lifecore Biomedical, Inc. \De\'s latest filing, its Liabilities and Shareholders Equity stood at $239.3 million for Q2 2025, which was down 575.6% from $237.7 million recorded in Q1 2025.
  • Lifecore Biomedical, Inc. \De\'s 5-year Liabilities and Shareholders Equity high stood at $506.9 million for Q1 2021, and its period low was $236.7 million during Q1 2023.
  • For the 5-year period, Lifecore Biomedical, Inc. \De\'s Liabilities and Shareholders Equity averaged around $304.3 million, with its median value being $254.7 million (2024).
  • In the last 5 years, Lifecore Biomedical, Inc. \De\'s Liabilities and Shareholders Equity soared by 7099.94% in 2021 and then tumbled by 4526.57% in 2022.
  • Lifecore Biomedical, Inc. \De\'s Liabilities and Shareholders Equity (Quarter) stood at $421.3 million in 2021, then crashed by 34.5% to $276.0 million in 2022, then decreased by 10.93% to $245.8 million in 2023, then grew by 3.89% to $255.4 million in 2024, then dropped by 6.28% to $239.3 million in 2025.
  • Its Liabilities and Shareholders Equity stands at $239.3 million for Q2 2025, versus $237.7 million for Q1 2025 and $255.4 million for Q4 2024.